-
EP3042659
European procedure
Extract from the Register of European Patents
EP Citations: EP3042659
| Cited in | Search | Type: | Patent literature | Publication No.: | US2002045643
[Y] (MULLER GEORGE W et al.) | Type: | Non-patent literature | Publication information: | [Y] CORRAL L G ET AL: "IMMUNOMODULATION BY THALIDOMIDE AND THALIDOMIDE ANALOGUES", ANNALS OF THE RHEUMATIC DISEASES, BRITISH MEDICAL ASSOCIATION, LONDON, GB, vol. 58, no. SUPPL. 01, 1 January 1999 (1999-01-01), pages I107 - I113, XP000861990, ISSN: 0003-4967 | Type: | Non-patent literature | Publication information: | [Y] LENTZSCH S ET AL: "S-3-amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 62, 15 April 2002 (2002-04-15), pages 2300 - 2305, XP002959459, ISSN: 0008-5472 | Type: | Non-patent literature | Publication information: | [Y] CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5 | DOI: | http://dx.doi.org/10.1007/3-540-69178-2_5 | Cited in | Opposition | Type: | Patent literature | Publication No.: | WO9803502
| Type: | Patent literature | Publication No.: | WO9803502
| Type: | Patent literature | Publication No.: | WO9803502
| Type: | Patent literature | Publication No.: | WO9803502
| Type: | Non-patent literature | Publication information: | STEPHEN BYM ET AL.: "Pharmaceutical solids: a strategic approach to regulatory considerations", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1995, XP055399407 | DOI: | http://dx.doi.org/10.1023/A:1016241927429 | Type: | Non-patent literature | Publication information: | MINO R. CAIRA: "Crystalline polymorphism of organic compounds", TOPICS IN CURRENT CHEMISTRY, vol. 198, 1998, XP008166276 | DOI: | http://dx.doi.org/10.1007/3-540-69178-2_5 | Type: | Non-patent literature | Publication information: | BRIAN S. FURNISS ET AL.,: "VOGEL'S TEXTBOOK OF PRACTICAL ORGANIC CHEMISTRY", 1989, PEARSON EDUCATION LIMITED, article "2.20 Recrystallization Techniques", pages: 135 - 139, XP055627461 | Type: | Non-patent literature | Publication information: | RICHARDSON ET AL.: "Thalidomide: Emerging Role in Cancer Medicine", ANNUAL REVIEW OF MEDICINE, vol. 53, February 2002 (2002-02-01), pages 629 - 657, XP055177555 | DOI: | http://dx.doi.org/10.1146/annurev.med.53.082901.104043 | Type: | Non-patent literature | Publication information: | ALFONSO GENNARO: "Remington`s Pharmaceutical Sciences", 1985, MACK PUBLISHING COMPANY, article "Molecular structure properties and states of matter", pages: 185, XP055443314 | Type: | Non-patent literature | Publication information: | ARMAREGO WILFRED L F; CHAI CHRISTINA L L: "PURIFICATION OF LABORATORY CHEMICALS, Fifth Edition", 2003, ELSEVIER SCIENCE (USA), article "Common Physical Techniques in Purification", pages: 14 - 16, XP055627845 | Type: | Non-patent literature | Publication information: | J.W. MULLIN: "CRYSTALLIZATION, Fourth Edition", 2001, REED EDUCATIONAL AND PROFESSIONAL PUBLISHING LTD., pages: 280-284, 300 - 302, XP055627847 | Type: | Non-patent literature | Publication information: | BYRN S. ET AL.: "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1995, pages 945 - 954, XP055399407 | DOI: | http://dx.doi.org/10.1023/A:1016241927429 | Type: | Non-patent literature | Publication information: | G. MUFTI ET AL.: "Myelodysplastic Syndrome", HEMATOLOGY, 2003, pages 176 - 199, XP055627855 | Type: | Non-patent literature | Publication information: | P.G. RICHARDSSON ET AL.: "Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma", BLOOD, vol. 100, 2002, pages 3063 - 3067, XP001188161 | DOI: | http://dx.doi.org/10.1182/blood-2002-03-0996 | Type: | Non-patent literature | Publication information: | STEPHEN BYRN ET AL.: "Pharmaceutical solids: a strategic approach to regulatory considerations", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1995, XP055399407 | DOI: | http://dx.doi.org/10.1023/A:1016241927429 | Type: | Non-patent literature | Publication information: | MINO R. CAIRA: "Crystalline polymorphism of organic compounds", TOPICS IN CURRENT CHEMISTRY, vol. 198, 1998, XP008166276 | DOI: | http://dx.doi.org/10.1007/3-540-69178-2_5 | Type: | Non-patent literature | Publication information: | BYRN ET AL.: "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1995, pages 945 - 954, XP055399407, doi:10.1023/A:1016241927429 | DOI: | http://dx.doi.org/10.1023/A:1016241927429 | Type: | Non-patent literature | Publication information: | BRIAN S FURNISS; ET AL: "Vogel's Textbook of Practical Organic Chemistry", 1989, pages: 135 - 139, XP055627461 | Type: | Non-patent literature | Publication information: | RICHARDSON ET AL.: "Thalidomide: Emerging Role in Cancer Medicine", ANNUAL REVIEW OF MEDICINE, vol. 53, February 2002 (2002-02-01), pages 629 - 657, XP055177555 | DOI: | http://dx.doi.org/10.1146/annurev.med.53.082901.104043 | Cited in | by applicant | Type: | Patent literature | Publication No.: | US5635517
| Type: | Patent literature | Publication No.: | US6281230
| Type: | Patent literature | Publication No.: | US41164903
| Type: | Patent literature | Publication No.: | US43821303
| Type: | Patent literature | Publication No.: | US41165603
| Type: | Patent literature | Publication No.: | US6235756
| Type: | Patent literature | Publication No.: | US6114335
| Type: | Patent literature | Publication No.: | US69379403
| Type: | Patent literature | Publication No.: | US69915403
| Type: | Non-patent literature | Publication information: | P. DIMARTINO ET AL., J. THERMAL ANAL., vol. 48, 1997, pages 447 - 458 | Type: | Non-patent literature | Publication information: | KNAPMAN, K., MODERN DRUG DISCOVERIES, vol. 53, 2000 | Cited in | other | Type: | Patent literature | Publication No.: | WO9803502
| Type: | Patent literature | Publication No.: | EP1667682
| Type: | Patent literature | Publication No.: | EP1667682
| Type: | Patent literature | Publication No.: | WO9803502
| Type: | Patent literature | Publication No.: | EP1667682
| Type: | Non-patent literature | Publication information: | JERRY MARCH: "Advanced Organic Chemistry - Reactions, Mechanisms, and Structure. 4th ed.", 1992, JOHN WILEY & SONS, pages: 1208,1216 - 1217, XP055500709 | Type: | Non-patent literature | Publication information: | RICHARDSON P. ET AL: "Thalidomide in multiple myeloma", BIOMED. PHARMACOTHER., vol. 56, no. 3, May 2002 (2002-05-01), pages 115 - 128, XP002507888 | DOI: | http://dx.doi.org/10.1016/S0753-3322(02)00168-3 | Type: | Non-patent literature | Publication information: | PATRICK A. J HASLETT ET AL: "Thalidomide and a Thalidomide Analogue Drug Costimulate Virus-Specific CD8+ T Cells In Vitro", THE JOURNAL OF INFECTIOUS DISEASES, vol. 187, no. 6, 15 March 2003 (2003-03-15), pages 946 - 955, XP009065694 | DOI: | http://dx.doi.org/10.1086/368126 | Type: | Non-patent literature | Publication information: | MULLER G. W. ET AL: "Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9, no. 11, 7 June 1999 (1999-06-07), pages 1625 - 1630, XP004169632 | DOI: | http://dx.doi.org/10.1016/S0960-894X(99)00250-4 |